Pancreatic Cancer Research

ResearcherConsorci Institut D'Investigacions Biomediques August Pi I SunyerActive in the last 2 years

Carles Barceló

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2551-2136; OpenAlex author ID A5050220567. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. Last author DOI 10.3390/ijms25052860↗
  2. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota. Last author DOI 10.3389/fonc.2022.995357↗
  3. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1053/j.gastro.2014.06.041↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Diego J. Jiménez · 1 shared paper, 2024 · strength 0.28
  2. Catalina M. Perelló-Reus · 1 shared paper, 2022 · strength 0.17
  3. Gabriel Capellá Munar · 1 shared paper, 2014 · strength 0.04
  4. Neus Agell Jané · 1 shared paper, 2014 · strength 0.04
  5. Victor Javier Sanchez-Arevalo Lobo · 1 shared paper, 2014 · strength 0.04
  6. Francisco X. Real · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.